GPR141
Probable G-protein coupled receptor 141
Also known as: GP141_HUMAN, PGR13
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z602
- Gene
- GPR141
- Ensembl
- ENSG00000187037
- Chromosome
- 7
- Canonical length
- 305 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
GPR141 is a member of the rhodopsin family of G protein-coupled receptors (GPRs) (Fredriksson et al., 2003 [PubMed 14623098]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
305 residues, UniProt reviewed canonical sequence.
>Q7Z602|GPR141
1 MPGHNTSRNS SCDPIVTPHL ISLYFIVLIG GLVGVISILF LLVKMNTRSV TTMAVINLVV
61 VHSVFLLTVP FRLTYLIKKT WMFGLPFCKF VSAMLHIHMY LTFLFYVVIL VTRYLIFFKC
121 KDKVEFYRKL HAVAASAGMW TLVIVIVVPL VVSRYGIHEE YNEEHCFKFH KELAYTYVKI
181 INYMIVIFVI AVAVILLVFQ VFIIMLMVQK LRHSLLSHQE FWAQLKNLFF IGVILVCFLP
241 YQFFRIYYLN VVTHSNACNS KVAFYNEIFL SVTAISCYDL LLFVFGGSHW FKQKIIGLWN
301 CVLCRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPR141 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 25 nTPM
- appendix: 3.7 nTPM
- spleen: 2.9 nTPM
- urinary bladder: 2.6 nTPM
- placenta: 1.9 nTPM
- gallbladder: 1.7 nTPM
Single-cell type
- neutrophil progenitors: 11 nCPM
- neutrophils: 10 nCPM
- mast cells: 8.6 nCPM
- monocyte progenitors: 4.2 nCPM
- nk-cells: 4.1 nCPM
- hematopoietic stem cells: 3.9 nCPM
Immune cell
- classical monocyte: 11 nTPM
- neutrophil: 11 nTPM
- eosinophil: 8 nTPM
- myeloid DC: 5.9 nTPM
- gdT-cell: 4.4 nTPM
- memory CD8 T-cell: 4.3 nTPM
Brain region
- medulla oblongata: 14 nTPM
- pons: 12 nTPM
- white matter: 12 nTPM
- thalamus: 11 nTPM
- cerebellum: 11 nTPM
- hypothalamus: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.94
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.48
- DepMap mean gene effect
- 0.21
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPR141 as an antibody target. Whether an autoantibody or antibody against GPR141 could matter depends on whether native GPR141 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPR141 is annotated at the cell surface, where native GPR141 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GPR141 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...